Zheng Jin

Title: The Innovative Contributions of Zheng Jin in Gastric Cancer Treatment

Introduction

Zheng Jin is a notable inventor based in Lanzhou, China. He has made significant contributions to the field of medicinal chemistry, particularly in the development of treatments for gastric cancer. His innovative work focuses on the application of trans-1,3-dilinolein, a compound with promising therapeutic potential.

Latest Patents

Zheng Jin holds a patent for the "Application of trans-1,3-dilinolein in the preparation of medicaments for treating gastric cancer, stomachic tonic, health products and foods." This patent outlines new uses of trans-1,3-dilinolein as both a medicament and a food additive. The research indicates that trans-1,3-dilinolein promotes the proliferation of human gastric mucosal epithelial cells under various conditions and exhibits a concentration-dependent killing effect on gastric cancer cells. Notably, at concentrations of 300 µm and above, trans-1,3-dilinolein significantly kills gastric cancer cells, with enhanced efficacy under hypoxic conditions.

Career Highlights

Zheng Jin is affiliated with Lanzhou University, where he conducts his research and development activities. His work has garnered attention for its potential impact on cancer treatment and health products.

Collaborations

Zheng Jin collaborates with esteemed colleagues, including Yanning Zhu and Ruyun Ma, who contribute to his research endeavors.

Conclusion

Zheng Jin's innovative work in the application of trans-1,3-dilinolein represents a significant advancement in the treatment of gastric cancer. His contributions to medicinal chemistry highlight the importance of research in developing effective therapies for serious health conditions.